← All stocks

PharmaCyte Biotech, Inc.

PMCB Net buying

CIK 0001157075 #5411 in the set updated 21 Sep 2026

Bought (12 mo)

$128.71K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$128.71K

+$128.71K against sales at will

By person

5 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Silverman Joshua

CEO and President

$80.48K (3)

—

+$80.48K

416,250

3.88%

$351.15K

—

SCHECHTER JONATHAN

Director

$48.23K (3)

—

+$48.23K

192,500

1.79%

$162.39K

+285.0%

WEINSTEIN ROBERT

Director

—

41,250

0.3842%

$34.80K

—

Abecassis Michael M

Director

—

22,292

0.2076%

$18.81K

+1,237%

WALKER WAYNE REMELL

Director

—

20,625

0.1921%

$17.40K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 11

Amendments (4/A) skipped 4

Filings about a different issuer 2

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,268,750

History held since 30 Dec 2022